Felix J Kim

Professor conducting influential research on prostate cancer, Dr. Felix J. Kim is an Associate Professor in the Department of Cancer Biology at Thomas Jefferson University. With a distinguished academic background, Dr. Kim earned his PhD from Université Montpellier, Centre National de la Recherche Scientifique in France, and a Bachelor of Science degree from the University of California San Diego. His academic journey was further enriched by a postdoctoral fellowship at the prestigious Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute in New York. Dr. Kim's research is primarily centered on the intricate mechanisms of prostate cancer, with a particular focus on Sigma1, a promising druggable target. Sigma1 is known to play a pivotal role in tumor biology, influencing metabolic rewiring and immune modulation. Dr. Kim's work aims to unravel the complexities of Sigma1's involvement in these processes, providing insights that could lead to groundbreaking therapeutic strategies. His ongoing projects delve into the mechanisms of action of Sigma1 modulators, seeking to understand how these compounds can be harnessed to disrupt cancer progression. By exploring the potential of Sigma1-targeting therapeutic agents, Dr. Kim's research holds promise for the development of novel treatments that could significantly impact patient outcomes. Dr. Kim's contributions to the field of cancer biology have been recognized through numerous publications and presentations at international conferences. His work not only advances scientific understanding but also has the potential to translate into tangible benefits for individuals affected by prostate cancer. In addition to his research endeavors, Dr. Kim is committed to mentoring the next generation of scientists. He actively engages with students and colleagues, fostering an environment of collaboration and innovation within the academic community. Through his dedication to both research and education, Dr. Kim continues to make significant strides in the fight against cancer.